Rifaximin in the treatment of hepatic encephalopathy
Maddalena Diana Iadevaia, Anna Del Prete, Claudia Cesaro, Laura Gaeta, Claudio Zulli, Carmelina LoguercioDepartment of Internistica Clinica e Sperimentale, F Magrassi e A Lanzara, Hepatogastroenterology Unit, Second University of Naples, Naples, ItalyAbstract: Hepatic encephalopathy is a challenging...
Enregistré dans:
Auteurs principaux: | Iadevaia MD, Del Prete A, Cesaro C, Gaeta L, Zulli C, Loguercio C |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7e2e851629b54db6874a1d0ff5ab8e86 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Economic impact of the use of rifaximin 550 mg twice daily for the treatment of overt hepatic encephalopathy in Italy
par: Roggeri DP, et autres
Publié: (2017) -
Overt hepatic encephalopathy in Italy: clinical outcomes and healthcare costs
par: Roggeri DP, et autres
Publié: (2015) -
Epidemiology and treatment of autoimmune hepatitis
par: Francque S, et autres
Publié: (2012) -
Hepatitis C in Argentina: epidemiology and treatment
par: Gaite LA, et autres
Publié: (2014) -
Interferon-free combination therapies for the treatment of hepatitis C: current insights
par: Holmes JA, et autres
Publié: (2015)